New class of biomimetic TAVR valve safe, feasible for severe aortic stenosis
In a first-in-human study, a new class of transcatheter heart valve demonstrated good safety and restored aortic blood flow to levels similar to a healthy aortic valve at 1 year, a speaker reported.The results of a prospective, single-center study evaluating the safety and feasibility of a biomimetic valve (DurAVR, Anteris) in patients with severe aortic stenosis undergoing transcatheter aortic